Abstract: A compound serving as a selective CDK inhibitor, a pharmaceutical composition containing same, a useful intermediate for preparing the compound, and a use of the compound for preparing a drug for the treatment of cell proliferative diseases, such as cancer. The compound has the structure shown in formula (I-A).

Abstract: Disclosed are a compound serving as a PARP7 inhibitor, and a use thereof in preparing a drug for treating relevant diseases. Specifically disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. The compound can be used for treating cancer.

Abstract: A touchpad and an electronic device are disclosed. The touchpad includes a touch panel; a plurality of pressure sensors fixed to an elastic bracket and configured to detect a pressure applied on the touch panel; a piezoelectric ceramic assembly including a piezoelectric ceramic plate configured to provide a vibration feedback to a user, where the piezoelectric ceramic assembly is fixed below the touch panel in a suspended manner and spaced from the elastic bracket.

Abstract: The present disclosure provides an ultrasonic-microwave synergistic extraction method of total saponins in beautiful millettia root, comprising the following steps: S1, material treatment, S2, cold soaking, S3 enzymatic hydrolysis, S4 extract extraction, and S5 ultrasonic-microwave synergistic extraction. The extraction method of the present disclosure extracts relatively high content of total saponins, and has relatively high yield of saponins and low content of impurities, and each step acts synergistically to solve the problems of relatively low total saponin content, more impumayrities and bubbling in the extraction process.

Abstract: The invention disclosed herein relates to aza-quinoline compounds of Formula (I), pharmaceutical compositions comprising such compounds, and the use of such compounds for treating a disease or condition mediated by Enhancer of Zeste Homolog 2 (EZH2), Polycomb Repressive Complex 2 (PRC2), or a combination thereof.

Abstract: The present disclosure provides an ultrasonic-microwave synergistic extraction method of total saponins in beautiful millettia root, comprising the following steps: S1, material treatment, S2, cold soaking, S3 enzymatic hydrolysis, S4 extract extraction, and S5 ultrasonic-microwave synergistic extraction. The extraction method of the present disclosure extracts relatively high content of total saponins, and has relatively high yield of saponins and low content of impurities, and each step acts synergistically to solve the problems of relatively low total saponin content, more impumayrities and bubbling in the extraction process.

Abstract: Disclosed are a collision check data processing method and apparatus, an electronic device, and a storage medium. The method comprises: acquiring generated collision check data, and acquiring an ID number of a collision part according to the collision check data; then acquiring ID numbers corresponding to selected designated parts from a preset database; and determining a target part under collision according to the ID numbers corresponding to the designated parts and the ID number of the collision part. According to the disclosure, a target part under collision can be determined among large amounts of collision check data according to an ID number corresponding to a designated part and an ID number of a collision part. That is, according to the disclosure, a single item among the collision check data can be checked according to a user requirement, thereby improving the check efficiency effectively.

Abstract: Provided aza-quinoline compounds of Formula (I), pharmaceutical compositions comprising such compounds; and the use of such compounds for treating a disease or condition mediate by Enhancer of Zeste Homolog 2 (EZH2), Polycomb Repressive Complex 2 (PRC2), or a combination thereof.

Abstract: A touchpad and an electronic device are disclosed. The touchpad includes a touch panel; a plurality of pressure sensors fixed to an elastic bracket and configured to detect a pressure applied on the touch panel; a piezoelectric ceramic assembly including a piezoelectric ceramic plate configured to provide a vibration feedback to a user, where the piezoelectric ceramic assembly is fixed below the touch panel in a suspended manner and spaced from the elastic bracket.

Abstract: Disclosed are a collision check data processing method and apparatus, an electronic device, and a storage medium. The method comprises: acquiring generated collision check data, and acquiring an ID number of a collision part according to the collision check data; then acquiring ID numbers corresponding to selected designated parts from a preset database; and determining a target part under collision according to the ID numbers corresponding to the designated parts and the ID number of the collision part. According to the disclosure, a target part under collision can be determined among large amounts of collision check data according to an ID number corresponding to a designated part and an ID number of a collision part. That is, according to the disclosure, a single item among the collision check data can be checked according to a user requirement, thereby improving the check efficiency effectively.

Abstract: The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

Abstract: The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

Abstract: The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

Abstract: The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

Abstract: The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).